• Tesetaxel + Capecitabine in HER2 Negative, HR Positive, MBC

  A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose of Capecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated with a Taxane

  Read More

• Optune® + Bevacizumab in Bevacizumab-RR Glioblastoma

  PHASE II TRIAL OF OPTUNE® PLUS BEVACIZUMAB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA

  Read More

• Radiation Therapy Plus Temozolomide and Pembrolizumab With and Wi

  A randomized, double blind phase II trial of Radiation Therapy plus Temozolomide and Pembrolizumab with and without HSPPC-96 in newly diagnosed Glioblastoma (GBM)

  Read More

• Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC

  Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) (150kHz) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

  Read More

• Vaccine Therapy for Newly Diagnosed Glioblastoma Multiforme

  ATTAC-II: A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells with Tetanus-Diphtheria Toxoid Vaccine in Patients with Newly-Diagnosed Glioblastoma

  Read More

• Brain Tumor Tissue Collection

  Florida Center for Brain Tumor Research

  Read More